| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V97.11.3466 |
| P698 | PubMed publication ID | 11369638 |
| P2093 | author name string | Kaliński P | |
| Kapsenberg ML | |||
| de Jong EC | |||
| Schuitemaker JH | |||
| Vieira PL | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3466-3469 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer | |
| P478 | volume | 97 |
| Q84099310 | Q84099310 |
| Q44245789 | A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy |
| Q43499769 | A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNgamma-stimulated macrophages |
| Q44233660 | A new era for innate immunity |
| Q39338676 | A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice |
| Q45119186 | A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. |
| Q35053422 | A role for inflammatory mediators in the induction of immunoregulatory B cells |
| Q35848222 | A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation |
| Q39853571 | Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation |
| Q44776861 | Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2. |
| Q44024646 | Ambivalent effects of dendritic cells displaying prostaglandin E2‐induced indoleamine 2,3‐dioxygenase |
| Q34105959 | Anti-HER2 vaccines: new prospects for breast cancer therapy |
| Q42003336 | Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells |
| Q41944042 | CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. |
| Q79150247 | CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response |
| Q35865581 | Cellular immunotherapy using dendritic cells against multiple myeloma |
| Q34132796 | Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections |
| Q39234940 | Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy |
| Q41440265 | Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion |
| Q35630534 | Controlling the Toll road to dendritic cell polarization |
| Q36448084 | Current state and perspectives of dendritic cell vaccination in cancer immunotherapy |
| Q44912942 | Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling. |
| Q93078777 | Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory? |
| Q38520811 | Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo |
| Q35212596 | Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation |
| Q47399887 | Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype |
| Q35826624 | Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy |
| Q35812979 | Dendritic cell therapy for skin cancer |
| Q37259624 | Dendritic cell-based cancer vaccination: quo vadis? |
| Q37773259 | Dendritic cell-based vaccines for the therapy of experimental tumors |
| Q79967042 | Dendritic cells in cancer immunotherapy |
| Q41520681 | Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? |
| Q37513871 | Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4 |
| Q83020708 | Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS |
| Q35077130 | Dendritic cells under the spell of prostaglandins |
| Q35146556 | Designing the optimal vaccine: the importance of cytokines and dendritic cells. |
| Q44385459 | Downregulation of interleukin-12p35 and upregulation of interleukin-12p40 mRNA expression in heart allografts by blood transfusion from granulocyte colony-stimulating factor-treated donors |
| Q57065138 | Effects of Jaw Periosteal Cells on Dendritic Cell Maturation |
| Q26778011 | Eicosanoid pathway in colorectal cancer: Recent updates |
| Q38672403 | Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. |
| Q38261273 | Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma. |
| Q34714672 | Epithelial crosstalk at the microbiota-mucosal interface. |
| Q37159089 | Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. |
| Q40041237 | Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion |
| Q33347561 | Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha |
| Q38148774 | Exploiting dendritic cells in the development of cancer vaccines |
| Q40668545 | Fibroblasts inhibit the production of interleukin-12p70 by murine dendritic cells |
| Q84639419 | Fibroblasts stimulated via HLA-II molecules produce prostaglandin E₂ and regulate cytokine production from helper T cells |
| Q53548271 | Fibroblasts support migration of monocyte-derived dendritic cells by secretion of PGE2 and MMP-1. |
| Q33804673 | Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularly |
| Q36090933 | Functional diversity and plasticity of human dendritic cell subsets |
| Q78468297 | Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection |
| Q36269842 | Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer Immunotherapy |
| Q43140456 | Generation of functional blocking monoclonal antibodies against mouse interleukin-12 p40 homodimer and monomer |
| Q81947651 | Generation of functionally mature dendritic cells from elutriated monocytes using polyinosinic : polycytidylic acid and soluble CD40 ligand for clinical application |
| Q44684461 | Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2). |
| Q41957729 | Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells |
| Q41876317 | Harnessing dendritic cells to generate cancer vaccines |
| Q37700841 | Harnessing human dendritic cell subsets for medicine |
| Q34672927 | Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells |
| Q27485530 | Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production |
| Q51983885 | Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells |
| Q28366668 | Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization |
| Q34453939 | How to Deal with Polarized Th2 Cells: Exploring the Achilles’ Heel |
| Q34142925 | Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus |
| Q34333969 | IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. |
| Q83191176 | IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction — A comparative study of human clinical-applicable DC |
| Q36403560 | IL-18-induced CD83+CCR7+ NK helper cells |
| Q36375426 | IL‐23‐dependent IL‐17 drives Th1‐cell responses following Mycobacterium bovis BCG vaccination |
| Q38855600 | Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in mice. |
| Q37420586 | Immune-checkpoint blockade and active immunotherapy for glioma |
| Q51610481 | Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12. |
| Q81809220 | Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells |
| Q35852574 | Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve? |
| Q36243536 | Immunotherapy of cancer in 2012 |
| Q36162929 | Immunotherapy of malignant brain tumors |
| Q90722007 | In Vitro Anti-Inflammatory and Immunomodulatory Activities of an Extract from the Roots of Bupleurum rotundifolium |
| Q90259996 | In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose |
| Q44787644 | Increased release of IL-12p70 by monocytes after periodontal therapy |
| Q40346494 | Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA. |
| Q36911452 | Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response |
| Q50328977 | Infective Larvae of Brugia malayi Induce Polarization of Host Macrophages that Helps in Immune Evasion |
| Q33734635 | Inhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Experimental Autoimmune Encephalomyelitis Induced in Mice |
| Q35206890 | Innate and adaptive determinants of host susceptibility to medically important fungi |
| Q40349921 | Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity |
| Q43429531 | Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages |
| Q33565624 | Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma |
| Q34273913 | Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection |
| Q61714881 | Interleukin-4 inhibits cyclo-oxygenase-2 expression and prostaglandin E production by human mature dendritic cells |
| Q52656382 | Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. |
| Q44968943 | Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells |
| Q36025111 | Isolation and generation of human dendritic cells |
| Q35876990 | Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function |
| Q84899471 | Leukotriene C4 prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance |
| Q28080521 | Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitus |
| Q36016330 | Lipopolysaccharide-Activated Dendritic Cells: “Exhausted” or Alert and Waiting? |
| Q34146882 | MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity |
| Q41968893 | Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. |
| Q58619973 | Maximizing dendritic cell migration in cancer immunotherapy |
| Q46977477 | Mechanisms of strain-dependent development of mast cells from mouse splenocytes |
| Q64996233 | Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands. |
| Q34613996 | Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis |
| Q34916497 | Monocyte-derived DC maturation strategies and related pathways: a transcriptional view |
| Q43040011 | Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile |
| Q34757680 | Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion |
| Q35839858 | Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors |
| Q34124931 | PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells |
| Q90047227 | PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma |
| Q38050458 | Peripheral blood monocyte responses in periodontitis |
| Q46694189 | Plasma cytokine changes in relation to exercise intensity and muscle damage. |
| Q37735454 | Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors |
| Q37857709 | Potential Clinical Applications for Human Pluripotent Stem Cell-Derived Blood Components |
| Q33735487 | Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia |
| Q51050849 | Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation |
| Q48219588 | Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. |
| Q89886586 | Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells |
| Q54597829 | Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells. |
| Q37859271 | Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection |
| Q36948594 | Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion |
| Q64080037 | Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation |
| Q33771051 | Regulation of CD154-induced interleukin-12 production in synovial fluid macrophages |
| Q26849305 | Regulation of immune responses by prostaglandin E2 |
| Q28388235 | Regulatory dendritic cells: there is more than just immune activation |
| Q36710729 | Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells |
| Q92441659 | Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill |
| Q34933694 | Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A |
| Q33865201 | Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells |
| Q58843220 | Selective maturation of dendritic cells byNippostrongylus brasiliensis-secreted proteins drives Th2 immune responses |
| Q41945985 | Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties |
| Q58662838 | Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses |
| Q52599699 | Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. |
| Q34238426 | Soluble mediators regulating immunity in early life |
| Q95310618 | T Cell Receptor Engineered Lymphocytes for Cancer Therapy |
| Q33666789 | T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. |
| Q41915647 | Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation |
| Q42830119 | The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2. |
| Q98224235 | The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases |
| Q80843163 | The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization |
| Q35210456 | The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors |
| Q38957065 | The role of dendritic cells in cancer |
| Q54498522 | The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses |
| Q41786456 | The yin and yang of intestinal epithelial cells in controlling dendritic cell function |
| Q37533657 | Toward effective immunotherapy for the treatment of malignant brain tumors |
| Q34484042 | Translating tumor antigens into cancer vaccines |
| Q49092861 | Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4. |
| Q37993359 | Tumor associated regulatory dendritic cells |
| Q39982625 | Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation. |
| Q43196387 | Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells |
| Q61863501 | Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling |
| Q42556100 | Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale |
| Q81354727 | [Active immunotherapy of prostate cancer with a focus on dendritic cells] |
| Q38071900 | mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. |
Search more.